{"id":"NCT00412971","sponsor":"Photocure","briefTitle":"A Randomized, Comparative Study of Hexvix Fluorescence Cystoscopy and Standard Cystoscopy in Patients With Non-invasive Bladder Cancer","officialTitle":"A Randomized, Comparative Phase III, 2-center Study of Hexvix Fluorescence Cystoscopy and Standard Cystoscopy in Patients With Non-invasive Bladder Cancer","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2005-04","primaryCompletion":"2008-10","completion":"2008-10","firstPosted":"2006-12-19","resultsPosted":"2013-10-11","lastUpdate":"2013-10-11"},"enrollment":233,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"DIAGNOSTIC"},"conditions":["Bladder Cancer"],"interventions":[{"type":"DRUG","name":"Hexvix","otherNames":[]},{"type":"OTHER","name":"Standard white light cystoscopy","otherNames":[]}],"arms":[{"label":"Hexvix cystoscopy group","type":"ACTIVE_COMPARATOR"},{"label":"White light","type":"OTHER"}],"summary":"The main objective of the study is to compare the 1-year recurrence rate of Hexvix assisted Transuretheral Resection of the Bladder (TURB) to standard white light TURB in patients with suspicion of non-invasive bladder cancer.\n\nThe hypothesis is to test whether the 1-year recurrence rate is different with Hexvix assisted TURB compared to standard white light TURB.","primaryOutcome":{"measure":"Proportion of Patients With Histologically Confirmed Recurrence Within One 1 Year.","timeFrame":"1 year","effectByArm":[{"arm":"Hexvix Cystoscopy Group","deltaMin":30.5,"sd":null},{"arm":"White Light","deltaMin":47.3,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.05"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":6},"locations":{"siteCount":2,"countries":["Denmark"]},"refs":{"pmids":["21414125"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":12,"n":112},"commonTop":["Urinary retention","Haematuria","Bladder perforation","Cystitis","Urinary tract infection"]}}